MMHA 6601 Week 3 Hospital-at-Home Appraisal Example

Dated and Weighed: An Evidence Appraisal of Hospital-at-Home and a Recommendation for a Conditioned Pilot

Student Name

Walden University

MMHA 6601: Technology and Innovations in Healthcare

Instructor Name

Month Day, Year

Dated and Weighed: An Evidence Appraisal of Hospital-at-Home and a Recommendation for a Conditioned Pilot

The Question

Ridgeway Health Partners, an invented group of fourteen primary care practices, has been approached by its partner hospital about a hospital-at-home program. Patients sick enough to need an inpatient bed for heart failure, pneumonia, cellulitis or a complicated urinary infection would be treated in their own homes instead. A nurse would visit at least twice a day, a physician once a day in person or by video, and a monitoring kit would send vital signs continuously, with a plan to move the patient to the hospital if their condition worsened. The hospital wants Ridgeway's physicians to refer patients and to manage follow-up after discharge from the home program. The network's leadership asked for an appraisal: what does the evidence show, how strong is it and should Ridgeway join?

This appraisal dates each source, describes its design and setting and weighs it before drawing a conclusion. The order matters because hospital-at-home has enthusiastic advocates, and a summary written verdict first would be tempted to collect only supportive studies.

Sources Appraised

Table 1

Sources, Design and Weight

Three sources span fifteen years and three designs. They agree on safety and patient experience and disagree, or are uncertain, on cost.

What the Evidence Supports

The strongest finding is that hospital-at-home is safe for carefully selected patients. Pooling the randomized trials, the Cochrane reviewers saw death rates over the following six months that were about the same whether patients stayed home or went to the ward, and readmission was lower in some of the analyses (Shepperd et al., 2016). The more recent US trial found that patients cared for at home had fewer readmissions within thirty days and spent less time lying in bed (Levine et al., 2020). The earlier US study found fewer complications, including less delirium, among older patients treated at home (Leff et al., 2005).

Patient and family satisfaction is consistently higher. This is plausible and matters for a primary care network whose patients will judge it partly by how their hospital episodes go. Families in the trials often described being able to stay together and keep routines, and older patients avoided the disorientation that a hospital ward can bring. For people with dementia or frailty, that difference is not a matter of comfort alone; delirium during a hospital stay is linked to longer recovery and loss of independence, and the earlier US study's finding of less delirium at home is one of its most important (Leff et al., 2005).

How the Sources Fit Together

The three sources should not be read as equally strong on every point. The Cochrane review carries the most weight on safety because it combines several trials, but many of those trials took place outside the United States, in health systems with different payment and staffing. The Boston trial is the closest to Ridgeway's setting in country and payment, but it was small, and it took place at two academic hospitals with a dedicated home team built for the study. The earlier US study adds weight on older patients, Ridgeway's largest group of admissions, but it was not randomized, so patients treated at home may have differed from those treated in hospital in ways that favored home.

Read together, the sources agree where their designs are strongest and diverge where each is weakest. That pattern is reassuring on safety and cautionary on cost, which is how the appraisal treats them.

What the Evidence Does Not Settle

Cost is the uncertain part. The randomized trial found lower costs for the acute episode at two academic hospitals (Levine et al., 2020), but the Cochrane review judged cost evidence across trials to be inconsistent (Shepperd et al., 2016). Costs depend heavily on payment: a program paid like an inpatient admission can be attractive to a hospital, while one paid at lower rates may not be. For Ridgeway, the hospital's finances matter only indirectly, but they decide whether the program survives past its first year, and a program that closes after a year leaves patients and practices with a disruption of their own. Results from academic centers with dedicated teams may also not transfer to a community hospital with fewer physicians.

Two further questions are not answered by any source here. First, how does hospital-at-home affect the primary care practice? None of the studies measured the work of follow-up after discharge from home, which is Ridgeway's role. Second, which patients in a mixed rural and suburban network can be served safely, given travel times for nurses and paramedics?

Recommendation

Ridgeway should join a limited pilot with stated conditions rather than commit network-wide. The evidence on safety and experience is strong enough to justify participation; the evidence on cost and on primary care workload is not strong enough to justify a broad commitment.

Table 2

Conditions for Ridgeway's Participation

Each condition responds to a gap or a limit in the evidence, so the pilot will produce the information the literature lacks.

Conclusion

Hospital-at-home is safe and well liked by patients when used for selected conditions, according to evidence of moderate to high quality across fifteen years. Its costs are uncertain, and its effect on primary care has not been studied. A three-practice pilot with conditions on diagnoses, distance, information sharing and workload tracking lets Ridgeway support a promising model while collecting the evidence it needs before going further.

References

Leff, B., Burton, L., Mader, S. L., Naughton, B., Burl, J., Inouye, S. K., Greenough, W. B., Guido, S., Langston, C., Frick, K. D., Steinwachs, D., & Burton, J. R. (2005). Hospital at home: Feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Annals of Internal Medicine, 143(11), 798-808. https://doi.org/10.7326/0003-4819-143-11-200512060-00008

Levine, D. M., Ouchi, K., Blanchfield, B., Saenz, A., Burke, K., Paz, M., Diamond, K., Pu, C. T., & Schnipper, J. L. (2020). Hospital-level care at home for acutely ill adults: A randomized controlled trial. Annals of Internal Medicine, 172(2), 77-85. https://doi.org/10.7326/M19-0600

Shepperd, S., Iliffe, S., Doll, H. A., Clarke, M. J., Kalra, L., Wilson, A. D., & Gonçalves-Bradley, D. C. (2016). Admission avoidance hospital at home. Cochrane Database of Systematic Reviews, 2016(9), CD007491. https://doi.org/10.1002/14651858.CD007491.pub2